Chicago Equity Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7,570
Closed -$1.36M 886
2017
Q3
$1.36M Buy
+7,570
New +$1.05M 0.04% 451

Chicago Equity Partners's KITE Position: Q4 2017 in Review

Chicago Equity Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 7,570 shares — an estimated $1.36M sold.

Chicago Equity Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $1.36M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Chicago Equity Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 7,570 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.36M.
  • Chicago Equity Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Chicago Equity Partners's Kite Pharma, Inc. position peaked at $1.36M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Chicago Equity Partners's 13F filing for Q4 2017, filed 31 Jan 2018.